pfizer glp-1 agonist pulls out of race after safety concerns Pfizer Discontinues Development of Investigational

Indian J Urol

Studies show it upregulates VEGF (vascular endothelial growth factor), which promotes blood vessel formation

Myers and Dr

Researchers study it for fat-cell shrinkage, higher NAD+ levels, and metabolic support without affecting appetite

Similar difference was observed for the placental tissue SOA between the two groups (5.93 0.78 mol/min/mg in RPL patients and 4.67 0.62 mol/min/mg in healthy pregnant women) [8]

Guirguis says combination treatments such as this could offer additive or synergistic effects meaning that patients have a better chance of responding to at least one of the mechanisms and could experience fewer GI side effects as a result of the dual approach